ICD-10 A81.09 is officially defined as "Other Creutzfeldt-Jakob disease." code A81.09 is referenced in 2 tracked payer policy changes from Humana and Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code A81.09 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Humana Louisiana Medicaid has implemented a new antipsychotic utilization program requiring prior authorization for antipsychotic medications prescribed to patients with documented dementia diagnoses. The program includes strict age-based criteria and specific compendia-supported indications for approval.
This Aetna policy addresses metagenomic next-generation sequencing, multiplex immunoassay tests, molecular syndromic panels and other tests for infectious diseases that do not fit in other bulletins. RT-QuIC is considered medically necessary for evaluating individuals with rapidly progressive dementia suspected of prion disease, and syphilis non-treponemal and treponemal tests are considered medically necessary for screening all pregnant women and persons at risk of syphilis, and for diagnostic testing of individuals with signs and symptoms of syphilis. Aetna considers named tests such as the Karius Test, IntelliSep, MeMed BV, TriVerity and the Synovasure Comprehensive PJI Test Panel experimental, investigational or unproven.
Watch A81.09
Get one email when a payer policy names A81.09, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.
Get alerts for changes like this
Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.